Cargando…
Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome
Patients with congenital agenesis of the portal vein may develop hepatocellular tumors due to enhanced arterial blood flow. These tumors may be benign (FNH, adenomas) or malignant (hepatoblastoma, HCC). Liver resection can be proposed, and preoperative arterial embolization may decrease blood loss d...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930207/ https://www.ncbi.nlm.nih.gov/pubmed/29744090 http://dx.doi.org/10.1002/ccr3.1384 |
_version_ | 1783319461491638272 |
---|---|
author | Christou, Niki Dib, Nabil Chuffart, Etienne Taibi, Abdelkader Durand‐Fontanier, Sylvaine Valleix, Denis Mathonnet, Muriel |
author_facet | Christou, Niki Dib, Nabil Chuffart, Etienne Taibi, Abdelkader Durand‐Fontanier, Sylvaine Valleix, Denis Mathonnet, Muriel |
author_sort | Christou, Niki |
collection | PubMed |
description | Patients with congenital agenesis of the portal vein may develop hepatocellular tumors due to enhanced arterial blood flow. These tumors may be benign (FNH, adenomas) or malignant (hepatoblastoma, HCC). Liver resection can be proposed, and preoperative arterial embolization may decrease blood loss during surgery. Liver transplantation with PV reconstruction is also an option. |
format | Online Article Text |
id | pubmed-5930207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-59302072018-05-09 Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome Christou, Niki Dib, Nabil Chuffart, Etienne Taibi, Abdelkader Durand‐Fontanier, Sylvaine Valleix, Denis Mathonnet, Muriel Clin Case Rep Case Reports Patients with congenital agenesis of the portal vein may develop hepatocellular tumors due to enhanced arterial blood flow. These tumors may be benign (FNH, adenomas) or malignant (hepatoblastoma, HCC). Liver resection can be proposed, and preoperative arterial embolization may decrease blood loss during surgery. Liver transplantation with PV reconstruction is also an option. John Wiley and Sons Inc. 2018-03-30 /pmc/articles/PMC5930207/ /pubmed/29744090 http://dx.doi.org/10.1002/ccr3.1384 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Christou, Niki Dib, Nabil Chuffart, Etienne Taibi, Abdelkader Durand‐Fontanier, Sylvaine Valleix, Denis Mathonnet, Muriel Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome |
title | Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome |
title_full | Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome |
title_fullStr | Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome |
title_full_unstemmed | Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome |
title_short | Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome |
title_sort | stepwise management of hepatocellular carcinoma associated with abernethy syndrome |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930207/ https://www.ncbi.nlm.nih.gov/pubmed/29744090 http://dx.doi.org/10.1002/ccr3.1384 |
work_keys_str_mv | AT christouniki stepwisemanagementofhepatocellularcarcinomaassociatedwithabernethysyndrome AT dibnabil stepwisemanagementofhepatocellularcarcinomaassociatedwithabernethysyndrome AT chuffartetienne stepwisemanagementofhepatocellularcarcinomaassociatedwithabernethysyndrome AT taibiabdelkader stepwisemanagementofhepatocellularcarcinomaassociatedwithabernethysyndrome AT durandfontaniersylvaine stepwisemanagementofhepatocellularcarcinomaassociatedwithabernethysyndrome AT valleixdenis stepwisemanagementofhepatocellularcarcinomaassociatedwithabernethysyndrome AT mathonnetmuriel stepwisemanagementofhepatocellularcarcinomaassociatedwithabernethysyndrome |